SCI Vision

The Stanford Cancer Institute is singularly able to catalyze the vast scientific, technological and human resources of Stanford University and Stanford Healthcare to advance understanding of cancer and rapidly translate research discoveries into improved prevention strategies and diagnostics, and safer, more effective therapies.

To achieve its mission, the SCI leadership and members relentlessly pursue multiple strategic aims

  1. Foster interdisciplinary basic cancer research, fueling discovery and innovation.

  2. Translate scientific discovery into clinical research and the optimal patient care.

  3. Develop improved approaches to the prevention, early detection, precise diagnosis and effective treatment of cancer.

  4. Transform the cancer patient experience by using research to develop and validate innovative initiatives in patient-centered care.

  5. Conduct research in SCI’s ten-county “catchment area” and disseminate effective risk assessment, prevention and early detection practices to this and other populations in the state of California and beyond.

  6. To train the next generation of cancer researchers in a rigorous and comprehensive manner.

In 2014 SCI launched the Stanford Cancer Initiative, an ambitious program to transform the care experience of every cancer patient, improving both quality of life and health outcomes. The multi-faceted Initiative is organized around four central mandates:

  • Creating a new standard of coordinated cancer care
  • Targeting the toughest cancers
  • Capturing the power of Stanford science
  • Seizing the innovations of our age


Embedded within Stanford University and the growing Stanford Healthcare network, SCI resides in aunique intellectual “ecosystem,” featuring a renown culture of innovation and breadth oftechnological capabilities. With the completion of the new hospital and modernization of the existingfacility in 2017, Stanford will have the nation’s most modern and innovative facility to treat cancerpatients.


SCI continuously integrates additional capabilities—including those of Stanford’s world-class bioengineering and information technology programs—that are of increasing importance in cancer research and in designing innovative care paradigms. Scholars in the Graduate School of Business andin the diverse social science departments offer valuable contributions on issues of cost control, quality improvement and dissemination. Perhaps most importantly, the School of Medicine’s stellar reputation in cancer research, supplemented by its international recognition in the basic sciences, stem cell biology, immunology and imaging, make Stanford a unique and dynamic environment in which to conduct cancer research and develop improved treatments.